News
We send the latest information from SMC Laboratories.
Announcement of webinar 【New NAFLD nomenclature ~Redefining the NAFLD/NASH mouse model~】
Today, we are excited to invite you to join our Webinar that will be taking place on August 18th from 9:30 AM (JST). In this webinar, we will focus on redefinition from NAFLD/NASH to MASLD/MASH. That is why we highly recommend that you join our free webinar! Webinar Link ►►► Click here …
Redefinition from NAFLD/NASH to MASLD/MASH
The American Association for the Study of Liver Disease (AASLD), the European Association for the Study of the Liver (EASL) and the Asociacion Latinoamericana para el Estudio del Higado (ALEH) have collaborated to present a statement on disease definitions, names and diagnostic methods for nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH). Title: A multi-society…
STAM™ Mice Is The Best NASH model For Microbiome Therapeutics Study
We are pleased to introduce the development of drugs for non-alcoholic steatohepatitis (NASH) focusing on the gut microbiome and overview of studies using our STAM™ mice. Currently, the development of treatment and prevention methods for various diseases targeting the gut microbiome is progressing around the world. The relationship between NASH and the gut microbiome,…
World Hepatitis Day 2023 ~ One life, one liver ~
In recognition of July 28th being World Hepatitis Day, we here at SMC thought it might be a good idea to help everyone around the globe have a deeper understanding of hepatitis, so please read on if you would like to learn more. In 2010, the World Health Organization (WHO) designated July 28th as…
Announcement of webinar 【Chronic kidney disease model ~Instructions on how to Tubular injury score】
Today, we are excited to invite you to join our Webinar that will be taking place on July 20th (JST) from 9:30 AM. In this webinar, we will focus on preclinical study for chronic kidney disease (CKD). In particular, we will introduce how to evaluate renal injury based on pathological findings, which is one…
Webinar Archive
I am writing you today to share with you about our Webinar. We occasionally organize webinars focusing on NASH and IPF, which are our primary areas of interest. We have previously conducted webinars on various topics, and the recordings are available in our webinar archive. ▶ Webinar archive [ Link ] The topics…
Announcement of webinar 【HOW NAFLD ACTIVITY SCORE IS SCORED IN NON-CLINICAL STUDIES】
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place on May 18th (JST) from 9:30 AM. In this webinar, we will introduce STAM™ mice and give a lecture on the NAFLD activity score scoring method recommended by the FDA as the primary endpoint of clinical…
March 9th is World Kidney Day!
Today, in celebration of World Kidney Day, we would like to share with you a little bit about the campaigns history, as well as what the purpose of it is. World Kidney Day aims to raise awareness of the important role that the kidney plays, as well as reduce kidney disease and other related health problems….
Introduction of Bile duct ligation (BDL)-induced primary biliary cirrhosis model
Today, we would like to introduce our bile duct ligation (BDL)-induced primary biliary cirrhosis disease model. This BDL model reproduces the pathological features of cholestatic liver disease, which leads to acute liver injury followed by liver inflammation and severe fibrosis. It is a great model for those looking to conduct in-vivo screening studies…
Announcement of webinar 【Creating high quality non-clinical study designs based on clinical trials】
Today we are excited to invite you to join our Online Linkedin Webinar that will be taking place on February 16th (JST) from 10:30 AM. In this webinar series we have being looking at examples of both clinical NASH trials as well as non-clinical study designs. For the 4th installment in this series, we…